Mewburn Ellis LLP
Located on Cambridge Business Park, our Cambridge office serves clients from Cambridge and around the world. We cover the full range of intellectual property issues: patents, trade marks, designs, industrial copyright and related matters, in all fields of technology.
|Telephone:||+44 (0)1223 420 383|
|Address:||The Maurice Wilkes Building, St John’s Innovation Park, Cambridge|
|Membership type:||Corporate 21-50 (£500+VAT pa)|
Please contact us for advice on any legal or commercial matter relating to intellectual property. Our areas of expertise include:
- advising on patentability and patenting strategy
- drafting and prosecuting patent applications in the UK and Europe
- handing patent oppositions and appeals at the European Patent Office
- advising on, filing, obtaining and defending trade marks and registered designs
- performing IP searching, due diligence and IP reports, including opinions on freedom to operate
- conducting "IP Audits" for businesses funded by partner schemes of the UK Intellectual Property Office, including GrowthAccelerator
- managing international portfolios of intellectual property rights
- advising on infringement of IP rights, including patents, trade marks, (registered and unregistered), designs (registered and unregistered) and copyright, and helping our clients to defend infringement proceedings brought against them
- dealing with other disputes relating to intellectual property, including pre-litigation contentious matters and preparing and advising on settlement agreements, providing litigation support and conducting patent litigation
- establishing entitlements to inventions, designs, copyright and trade marks including preparing any documents necessary to put in place an unbroken chain of title
- advising on and preparing documents relating to technology transfer, including assignment and licensing of patents, designs, copyright and know-how, trade secrets and confidential information; and
- recording assignments, licences and name changes in relation to intellectual property in jurisdictions throughout the world.
We cover all technical fields, including biotechnology & life sciences, pharmaceuticals, chemistry, computers and software, electronics and mechanical engineering.
Early-stage biotech companies are often founded based on the exciting results of pre-clinical research relating to a new product or treatment. However, due to the need for refinement/development and the extensive work required to demonstrate safety and efficacy in order to obtain regulatory approval, early-stage biotech companies are often a long way away from bringing a new drug or therapy to market.
20 December 2018Read in full
Massive social, economic and technology trends are converging to change mobility - how we move things from point A to point B, whether that is people, goods or containers. All of these drivers of change are self-reinforcing.
19 December 2018Read in full
Cadbury has been dealt a blow by the Court of Appeal in its battle to maintain its trade mark for the colour purple which it uses across all of its chocolate bars. On 5 December 2018 the Court of Appeal confirmed the previous decisions of the UK Intellectual Property Office and the High Court, and refused to accept that Cadbury’s registration is for a series of two different marks.
18 December 2018Read in full
In recent years, we have witnessed a remarkable healthcare revolution. Thanks to advances in genetic analysis, molecular biology and cell science, we now know more about the human condition than ever before. This wealth of information opens the door for the next revolution in medicine – treatments that are truly bespoke for each patient.
17 December 2018Read in full
A further step towards a withdrawal agreement between the UK and EU27 occurred on 14 November 2018 with the publication of the fully negotiated version of the draft withdrawal agreement by the European Commission.
4 December 2018Read in full
The UK Supreme Court issued its decision today on the Warner Lambert vs Generics (UK) Ltd t/a Mylan. The decision concerns Swiss-form patent claims that relate to a specified medical use of a known pharmaceutical compound, in this case the use of pregabalin to treat pain. Nick Sutcliffe of Mewburn Ellis comments.
3 December 2018Read in full
The Cambridge office of Mewburn Ellis LLP moved on 26 November to the prestigious St John’s Innovation Park at the centre of the North Cambridge Research and Development Cluster, as the firm continues to expand.
28 November 2018Read in full
European Patent Office (EPO) Guidelines on the evidence required to transfer European applications have changed.
21 November 2016Read in full
The UK Intellectual Property Office has just issued a guide to the implications of Brexit for IP rights owned by UK companies. While copyright and both UK and European patents are likely to be unaffected, the uncertainty with respect to EU Trade Marks (EUTM), Registered Community Designs (RCD) and the Unified Patent Court remains to be resolved.
4 August 2016Read in full